首页 > 最新文献

DeckerMed Medicine最新文献

英文 中文
Crohn Disease in Childhood and Adolescence 儿童和青少年的克罗恩病
Pub Date : 2018-08-26 DOI: 10.2310/im.5604
Lori A. Zimmerman
Crohn disease (CD) is a chronic inflammatory condition that can occur throughout the gastrointestinal tract (the mouth to the anus). CD is classified by location within the gastrointestinal tract and behavior of the disease (inflammatory, penetrating, and/or stricturing). It can also affect the extraintestinal tissue and cause perianal disease. It occurs from a complex interplay of genetic predisposition, altered gut microbiota, immunologic dysregulation, and likely environmental triggers. Children with CD often present with signs and symptoms related to the inflammation within their gastrointestinal tract. Most children with CD will present with diarrhea and abdominal pain, whereas some will present with rectal bleeding, fevers, weight loss, perianal disease, or joint disease. There is no single test to confidently diagnose a patient with CD. Instead, clinicians rely on a combination of biomarkers in the serum and stool, imaging studies, and endoscopic evaluation to make the diagnosis. The general aims of treatment of children with CD are to induce and maintain clinical remission of disease, optimize nutrition and growth, minimize adverse effects of therapies, and ultimately target mucosal healing.This review contains 3 figures, 3 tables and 34 references.Key Words: biologics, child, chronic diarrhea, Crohn disease, hematochezia, inflammatory bowel disease, immunodeficiency, pediatric, weight loss
克罗恩病(CD)是一种慢性炎症,可发生在整个胃肠道(从嘴到肛门)。乳糜泻是根据胃肠道内的位置和疾病表现(炎症性、穿透性和/或狭窄性)来分类的。它还能影响肠外组织并引起肛周疾病。它是由遗传易感性、肠道菌群改变、免疫失调和可能的环境触发因素复杂的相互作用而发生的。乳糜泻患儿通常表现出与胃肠道炎症相关的体征和症状。大多数乳糜泻患儿会出现腹泻和腹痛,而有些患儿会出现直肠出血、发烧、体重减轻、肛周疾病或关节疾病。没有单一的测试可以自信地诊断乳糜泻患者。相反,临床医生依靠血清和粪便中的生物标志物、影像学检查和内窥镜评估来做出诊断。儿童乳糜泻治疗的总体目标是诱导和维持疾病的临床缓解,优化营养和生长,尽量减少治疗的不良反应,并最终以粘膜愈合为目标。本文共包含图3张,表3张,参考文献34篇。关键词:生物制剂,儿童,慢性腹泻,克罗恩病,便血,炎症性肠病,免疫缺陷,儿童,体重减轻
{"title":"Crohn Disease in Childhood and Adolescence","authors":"Lori A. Zimmerman","doi":"10.2310/im.5604","DOIUrl":"https://doi.org/10.2310/im.5604","url":null,"abstract":"Crohn disease (CD) is a chronic inflammatory condition that can occur throughout the gastrointestinal tract (the mouth to the anus). CD is classified by location within the gastrointestinal tract and behavior of the disease (inflammatory, penetrating, and/or stricturing). It can also affect the extraintestinal tissue and cause perianal disease. It occurs from a complex interplay of genetic predisposition, altered gut microbiota, immunologic dysregulation, and likely environmental triggers. Children with CD often present with signs and symptoms related to the inflammation within their gastrointestinal tract. Most children with CD will present with diarrhea and abdominal pain, whereas some will present with rectal bleeding, fevers, weight loss, perianal disease, or joint disease. There is no single test to confidently diagnose a patient with CD. Instead, clinicians rely on a combination of biomarkers in the serum and stool, imaging studies, and endoscopic evaluation to make the diagnosis. The general aims of treatment of children with CD are to induce and maintain clinical remission of disease, optimize nutrition and growth, minimize adverse effects of therapies, and ultimately target mucosal healing.\u0000This review contains 3 figures, 3 tables and 34 references.\u0000Key Words: biologics, child, chronic diarrhea, Crohn disease, hematochezia, inflammatory bowel disease, immunodeficiency, pediatric, weight loss","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83150330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Transplant Immunology 2: Application to Liver Allograft Immunity 肝移植免疫学2:在同种异体肝移植免疫中的应用
Pub Date : 2018-08-20 DOI: 10.2310/im.14075
M. Kriss, H. Rosen
The liver is a multifunctional organ responsible for complex metabolic and immune functions. Although not a classic lymphoid organ, the liver is enriched with traditional immune cells as well as parenchymal and nonparenchymal cells that play a key role in immune homeostasis. Due to its location and unique anatomic structure, the liver must finely balance immunity and tolerance to avoid undue inflammation in the setting of constant antigenic exposure from portal blood flow while maintaining appropriate immunity against pathogens. Since the first successful liver transplantation in humans in 1967 at the University of Colorado, our knowledge of hepatic immunity and tolerance, in the context of both liver disease and liver transplantation, has evolved dramatically. With these advancements, therapeutic modalities have been developed that have revolutionized the care of liver transplant recipients.  In Part 2: Application to Liver Allograft Immunity, we apply the basic principles of liver immunology and allorecognition to our current management of liver transplant recipients in the context of both immunosuppression and the holy grail of transplantation, operational tolerance.This review contains 4 figures, 3 tables, and 32 referencesKey Words: adaptive immunity; allograft rejection; allograft tolerance; allorecognition; antigen presenting cells; immunosuppression; innate immunity; liver transplantation; T lymphocytes
肝脏是一个多功能器官,负责复杂的代谢和免疫功能。肝脏虽然不是典型的淋巴器官,但富含传统的免疫细胞以及在免疫稳态中起关键作用的实质细胞和非实质细胞。由于其位置和独特的解剖结构,肝脏必须精细地平衡免疫和耐受性,以避免在门静脉血流中持续暴露抗原的情况下过度炎症,同时保持对病原体的适当免疫。自1967年科罗拉多大学首次成功进行人类肝移植以来,我们对肝脏免疫和耐受性的认识,在肝脏疾病和肝移植的背景下,都有了巨大的发展。随着这些进步,治疗方式的发展已经彻底改变了肝移植受者的护理。在第2部分:肝移植免疫的应用中,我们将肝脏免疫学和同种异体识别的基本原理应用于我们目前在免疫抑制和移植的圣杯——手术耐受的背景下对肝移植受者的管理。全文包括4图3表32篇文献关键词:适应性免疫;同种异体移植物排斥反应;同种异体移植物耐受;allorecognition;抗原呈递细胞;免疫抑制;先天免疫;肝移植;T淋巴细胞
{"title":"Liver Transplant Immunology 2: Application to Liver Allograft Immunity","authors":"M. Kriss, H. Rosen","doi":"10.2310/im.14075","DOIUrl":"https://doi.org/10.2310/im.14075","url":null,"abstract":"The liver is a multifunctional organ responsible for complex metabolic and immune functions. Although not a classic lymphoid organ, the liver is enriched with traditional immune cells as well as parenchymal and nonparenchymal cells that play a key role in immune homeostasis. Due to its location and unique anatomic structure, the liver must finely balance immunity and tolerance to avoid undue inflammation in the setting of constant antigenic exposure from portal blood flow while maintaining appropriate immunity against pathogens. Since the first successful liver transplantation in humans in 1967 at the University of Colorado, our knowledge of hepatic immunity and tolerance, in the context of both liver disease and liver transplantation, has evolved dramatically. With these advancements, therapeutic modalities have been developed that have revolutionized the care of liver transplant recipients.  In Part 2: Application to Liver Allograft Immunity, we apply the basic principles of liver immunology and allorecognition to our current management of liver transplant recipients in the context of both immunosuppression and the holy grail of transplantation, operational tolerance.\u0000\u0000This review contains 4 figures, 3 tables, and 32 references\u0000Key Words: adaptive immunity; allograft rejection; allograft tolerance; allorecognition; antigen presenting cells; immunosuppression; innate immunity; liver transplantation; T lymphocytes","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85730126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posttransplant Complications: Renal, Cardiovascular, Diabetes, and Obesity 移植后并发症:肾脏、心血管、糖尿病和肥胖
Pub Date : 2018-08-19 DOI: 10.2310/im.14056
Pranab M. Barman, J. Levitsky
With improving surgical technique and perioperative care, liver transplant recipients will continue to survive longer and longer. After the first year of transplantation, the risk of mortality is largely based on the development of renal disease and metabolic syndrome, including hypertension, hyperlipidemia, diabetes, and obesity. Mechanistically, these complications can be a result of immunosuppressive medications as well as a return to poor dietary and exercise regimens posttransplant. Renal injury is almost exclusively a result of calcineurin toxicity over time, and new strategies are in place, utilizing mammalian target of rapamycin inhibitors to minimize this risk. Cardiovascular complications can also be spurred on by immunosuppressive medications, and close monitoring and treatment with standard agents are required in the recipient. Diabetes is perhaps the most feared medical complication posttransplant, as it carries a higher risk of mortality. It is also impacted by many of the different immunosuppressive regimens. Finally, novel strategies are being researched to appropriately treat the obese patient pre- and post liver transplant.This review contains 1 figure, 2 tables, and 52 references.Key Words: complications, diabetes, everolimus, immunosuppression, liver transplant, medical, metabolic syndrome, obesity, posttransplant, renal disease, tacrolimus.
随着手术技术和围手术期护理的提高,肝移植受者的生存时间将越来越长。移植一年后,死亡风险主要取决于肾脏疾病和代谢综合征的发展,包括高血压、高脂血症、糖尿病和肥胖。从机制上讲,这些并发症可能是免疫抑制药物以及移植后不良饮食和运动方案的结果。随着时间的推移,肾损伤几乎完全是钙调磷酸酶毒性的结果,新的策略已经到位,利用雷帕霉素抑制剂的哺乳动物靶点来减少这种风险。免疫抑制药物也可诱发心血管并发症,需要对受者进行密切监测并使用标准药物进行治疗。糖尿病可能是移植后最可怕的医学并发症,因为它具有更高的死亡率。它也受到许多不同的免疫抑制方案的影响。最后,新的策略正在研究,以适当地治疗肥胖患者肝移植前后。本综述包含1张图,2张表,52篇参考文献。关键词:并发症,糖尿病,依维莫司,免疫抑制,肝移植,医学,代谢综合征,肥胖,移植后,肾脏疾病,他克莫司
{"title":"Posttransplant Complications: Renal, Cardiovascular, Diabetes, and Obesity","authors":"Pranab M. Barman, J. Levitsky","doi":"10.2310/im.14056","DOIUrl":"https://doi.org/10.2310/im.14056","url":null,"abstract":"With improving surgical technique and perioperative care, liver transplant recipients will continue to survive longer and longer. After the first year of transplantation, the risk of mortality is largely based on the development of renal disease and metabolic syndrome, including hypertension, hyperlipidemia, diabetes, and obesity. Mechanistically, these complications can be a result of immunosuppressive medications as well as a return to poor dietary and exercise regimens posttransplant. Renal injury is almost exclusively a result of calcineurin toxicity over time, and new strategies are in place, utilizing mammalian target of rapamycin inhibitors to minimize this risk. Cardiovascular complications can also be spurred on by immunosuppressive medications, and close monitoring and treatment with standard agents are required in the recipient. Diabetes is perhaps the most feared medical complication posttransplant, as it carries a higher risk of mortality. It is also impacted by many of the different immunosuppressive regimens. Finally, novel strategies are being researched to appropriately treat the obese patient pre- and post liver transplant.\u0000\u0000This review contains 1 figure, 2 tables, and 52 references.\u0000Key Words: complications, diabetes, everolimus, immunosuppression, liver transplant, medical, metabolic syndrome, obesity, posttransplant, renal disease, tacrolimus.","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74125944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Acute Pneumonia 急性肺炎
Pub Date : 2018-08-01 DOI: 10.2310/im.1140
J. I. Hogan, B. Davis
Acute pneumonia continues to represent a major source of morbidity, mortality, and healthcare expenditure in the U.S. It is imperative that clinicians at all levels of training have a firm understanding of this potentially deadly infection and its numerous complications. The current state of our diagnostic capabilities often dictates that clinicians will need to make important therapeutic decisions in patients presenting with acute pneumonia before identifying a culprit pathogen. Only after understanding the pathogenesis of pneumonia under different clinical circumstances can one devise rational empiric therapeutic regimens. In this practical review we offer a succinct description of the epidemiology and pathogenesis of acute pneumonia. We then proceed to discuss the evaluation and management of patients presenting with acute pneumonia with emphasis on the most valuable clinical trials and major guidelines that we use to inform our clinical decisions. Despite significant advances in the field of infectious disease over the past century, clinicians continue to recognize pneumonia, the infection of the pulmonary parenchyma, as a major source of morbidity and mortality. In this article we attempt to provide the general practitioner with a practical review of acute pneumonia and its complications. Prioritizing the needs of the general practitioner, we most thoroughly address community acquired pneumonia (CAP). Though we do not intend for this review to be completely comprehensive, in this article we also briefly discuss healthcare associated pneumonia (HCAP), hospital associated pneumonia (HAP), and ventilator associated pneumonia (VAP). Focusing much of our attention on the most important clinical trials and guidelines underpinning the diagnosis and management of this common problem, we hope that this publication will serve as a useful review to aid in clinical decision making.This review contains 65 references, 1 figure and 6 tables.Key Words: Pneumonia, viral pneumonia, bacterial pneumonia, community-acquired pneumonia, ventilator-associated pneumonia, VAP, healthcare-associated pneumonia, hospital-acquired pneumonia 
急性肺炎仍然是美国发病率、死亡率和医疗支出的主要来源。各级培训的临床医生必须对这种潜在的致命感染及其众多并发症有一个坚定的了解。我们目前的诊断能力往往表明,临床医生需要在确定罪魁祸首病原体之前,对出现急性肺炎的患者做出重要的治疗决定。只有了解不同临床情况下肺炎的发病机制,才能设计出合理的经验性治疗方案。在这个实际的审查,我们提供了一个简短的描述流行病学和发病机制的急性肺炎。然后我们继续讨论急性肺炎患者的评估和管理,重点是最有价值的临床试验和我们用来指导临床决策的主要指南。尽管在过去的一个世纪里,传染病领域取得了重大进展,但临床医生仍然认为肺炎(肺实质感染)是发病率和死亡率的主要来源。在这篇文章中,我们试图为全科医生提供一个实用的回顾急性肺炎及其并发症。优先考虑全科医生的需要,我们最彻底地解决社区获得性肺炎(CAP)。虽然我们不打算完全全面地回顾这篇文章,但在这篇文章中,我们还简要讨论了医疗保健相关性肺炎(HCAP)、医院相关性肺炎(HAP)和呼吸机相关性肺炎(VAP)。我们将注意力集中在最重要的临床试验和指导方针上,以支持这一常见问题的诊断和管理,我们希望本出版物将作为一种有用的回顾,以帮助临床决策。本文共收录文献65篇,图1张,表6张。关键词:肺炎,病毒性肺炎,细菌性肺炎,社区获得性肺炎,呼吸机相关性肺炎,VAP,卫生保健相关性肺炎,医院获得性肺炎
{"title":"Acute Pneumonia","authors":"J. I. Hogan, B. Davis","doi":"10.2310/im.1140","DOIUrl":"https://doi.org/10.2310/im.1140","url":null,"abstract":"Acute pneumonia continues to represent a major source of morbidity, mortality, and healthcare expenditure in the U.S. It is imperative that clinicians at all levels of training have a firm understanding of this potentially deadly infection and its numerous complications. The current state of our diagnostic capabilities often dictates that clinicians will need to make important therapeutic decisions in patients presenting with acute pneumonia before identifying a culprit pathogen. Only after understanding the pathogenesis of pneumonia under different clinical circumstances can one devise rational empiric therapeutic regimens. In this practical review we offer a succinct description of the epidemiology and pathogenesis of acute pneumonia. We then proceed to discuss the evaluation and management of patients presenting with acute pneumonia with emphasis on the most valuable clinical trials and major guidelines that we use to inform our clinical decisions. Despite significant advances in the field of infectious disease over the past century, clinicians continue to recognize pneumonia, the infection of the pulmonary parenchyma, as a major source of morbidity and mortality. In this article we attempt to provide the general practitioner with a practical review of acute pneumonia and its complications. Prioritizing the needs of the general practitioner, we most thoroughly address community acquired pneumonia (CAP). Though we do not intend for this review to be completely comprehensive, in this article we also briefly discuss healthcare associated pneumonia (HCAP), hospital associated pneumonia (HAP), and ventilator associated pneumonia (VAP). Focusing much of our attention on the most important clinical trials and guidelines underpinning the diagnosis and management of this common problem, we hope that this publication will serve as a useful review to aid in clinical decision making.\u0000This review contains 65 references, 1 figure and 6 tables.\u0000Key Words: Pneumonia, viral pneumonia, bacterial pneumonia, community-acquired pneumonia, ventilator-associated pneumonia, VAP, healthcare-associated pneumonia, hospital-acquired pneumonia\u0000 ","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75152504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and Treatment of Pediatric Obesity 儿童肥胖的评估与治疗
Pub Date : 2018-07-16 DOI: 10.2310/im.5605
N. Desai, S. Softic
Obesity is one of the most significant health problems facing children and adolescents. The definition of overweight in children is a body mass index between the 85th and less than 95th percentile, whereas obesity is greater than or equal to the 95th percentile for age and sex. There are multiple comorbidities associated with obesity, including dyslipidemia, hypertension, type 2 diabetes, sleep apnea, and nonalcoholic fatty liver disease, as well as psychosocial issues. This review contains 3 figures, 4 tables and 63 references.Key Words bariatric surgery, metabolic syndrome, obesity treatment, pediatric obesity, weight loss surgery
肥胖是儿童和青少年面临的最严重的健康问题之一。儿童超重的定义是体重指数在85到95个百分位数之间,而肥胖则是在年龄和性别上大于或等于95个百分位数。与肥胖相关的合并症有多种,包括血脂异常、高血压、2型糖尿病、睡眠呼吸暂停、非酒精性脂肪肝以及社会心理问题。本综述包含图3张,表4张,参考文献63篇。关键词:减肥手术,代谢综合征,肥胖治疗,小儿肥胖,减肥手术
{"title":"Evaluation and Treatment of Pediatric Obesity","authors":"N. Desai, S. Softic","doi":"10.2310/im.5605","DOIUrl":"https://doi.org/10.2310/im.5605","url":null,"abstract":"Obesity is one of the most significant health problems facing children and adolescents. The definition of overweight in children is a body mass index between the 85th and less than 95th percentile, whereas obesity is greater than or equal to the 95th percentile for age and sex. There are multiple comorbidities associated with obesity, including dyslipidemia, hypertension, type 2 diabetes, sleep apnea, and nonalcoholic fatty liver disease, as well as psychosocial issues. \u0000\u0000This review contains 3 figures, 4 tables and 63 references.\u0000Key Words bariatric surgery, metabolic syndrome, obesity treatment, pediatric obesity, weight loss surgery","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84071778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diet and Exercise in the Treatment of Obesity 饮食和运动治疗肥胖
Pub Date : 2018-07-05 DOI: 10.2310/IM.9024
Meghan Ariagno
This review addresses the role of nutrition and physical activity in weight management. There is not one standardized approach toward weight loss, but research demonstrates the effectiveness of following a reduced-calorie plan, as well as emphasizing increases in physical activity. Other important elements of consideration include promoting contact with weight management clinicians to provide structure, encouragement, and support. Physical activity alone has not been proven to support weight loss but in combination with a lower caloric intake can be helpful toward achieving weight loss. Sustaining weight loss is difficult for most individuals, so the support of clinicians is valuable not only in the starting phase but in the long term as well. This review contains 1 figure, 4 tables and 37 referencesKey words: activity, calorie, carbohydrate, diet, dietitian, exercise, intervention, lifestyle, maintenance, obesity, portion, technology, weight
这篇综述论述了营养和身体活动在体重管理中的作用。没有一种标准化的减肥方法,但研究表明,遵循减少卡路里的计划以及强调增加体育活动是有效的。其他重要的考虑因素包括促进与体重管理临床医生的联系,以提供结构、鼓励和支持。体育活动本身并不能证明有助于减肥,但结合低热量摄入可以帮助实现减肥。对于大多数人来说,维持减肥是困难的,因此临床医生的支持不仅在开始阶段而且在长期也是有价值的。关键词:活动,热量,碳水化合物,饮食,营养师,运动,干预,生活方式,维持,肥胖,部分,技术,体重
{"title":"Diet and Exercise in the Treatment of Obesity","authors":"Meghan Ariagno","doi":"10.2310/IM.9024","DOIUrl":"https://doi.org/10.2310/IM.9024","url":null,"abstract":"This review addresses the role of nutrition and physical activity in weight management. There is not one standardized approach toward weight loss, but research demonstrates the effectiveness of following a reduced-calorie plan, as well as emphasizing increases in physical activity. Other important elements of consideration include promoting contact with weight management clinicians to provide structure, encouragement, and support. Physical activity alone has not been proven to support weight loss but in combination with a lower caloric intake can be helpful toward achieving weight loss. Sustaining weight loss is difficult for most individuals, so the support of clinicians is valuable not only in the starting phase but in the long term as well. \u0000\u0000This review contains 1 figure, 4 tables and 37 references\u0000Key words: activity, calorie, carbohydrate, diet, dietitian, exercise, intervention, lifestyle, maintenance, obesity, portion, technology, weight","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87157466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Techniques For Assessment Of Body Composition In Health 健康人体成分评估技术
Pub Date : 2018-07-03 DOI: 10.2310/im.9001
C. M. Prado, Camila L. P. Oliveira, M. Gonzalez, Steven B Heymsfield
Body composition assessment is an important tool in both clinical and research settings able to characterize the nutritional status of individuals in various physiologic and pathologic conditions. Health care professionals can use the information acquired by body composition analysis for the prevention and treatment of diseases, ultimately improving health status. Here we describe commonly used techniques to assess body composition in healthy individuals, including dual-energy x-ray absorptiometry, bioelectrical impedance analysis, air displacement plethysmography, and ultrasonography. Understanding the key underlying concept(s) of each assessment method, as well as its advantages and limitations, facilitates selection of the method of choice and the method of the compartment of interest.This review contains 5 figures, 3 tables and 52 referencesKey words: air displacement plethysmography, bioelectrical impedance analysis, body composition, disease, dual-energy x-ray absorptiometry, health, muscle mass, nutritional status, obesity, sarcopenia, ultrasound fat mass
身体成分评估是临床和研究环境中的重要工具,能够表征个体在各种生理和病理条件下的营养状况。卫生保健专业人员可以利用身体成分分析获得的信息来预防和治疗疾病,最终改善健康状况。在这里,我们描述了评估健康人身体成分的常用技术,包括双能x线吸收仪、生物电阻抗分析、空气置换容积脉搏图和超声检查。了解每种评估方法的关键基本概念及其优点和局限性,有助于选择选择方法和兴趣区隔方法。本文共包含5图3表52篇参考文献。关键词:空气置换脉搏波,生物阻抗分析,身体组成,疾病,双能x线吸收仪,健康,肌肉量,营养状况,肥胖,肌肉减少症,超声脂肪量
{"title":"Techniques For Assessment Of Body Composition In Health","authors":"C. M. Prado, Camila L. P. Oliveira, M. Gonzalez, Steven B Heymsfield","doi":"10.2310/im.9001","DOIUrl":"https://doi.org/10.2310/im.9001","url":null,"abstract":"Body composition assessment is an important tool in both clinical and research settings able to characterize the nutritional status of individuals in various physiologic and pathologic conditions. Health care professionals can use the information acquired by body composition analysis for the prevention and treatment of diseases, ultimately improving health status. Here we describe commonly used techniques to assess body composition in healthy individuals, including dual-energy x-ray absorptiometry, bioelectrical impedance analysis, air displacement plethysmography, and ultrasonography. Understanding the key underlying concept(s) of each assessment method, as well as its advantages and limitations, facilitates selection of the method of choice and the method of the compartment of interest.\u0000This review contains 5 figures, 3 tables and 52 references\u0000Key words: air displacement plethysmography, bioelectrical impedance analysis, body composition, disease, dual-energy x-ray absorptiometry, health, muscle mass, nutritional status, obesity, sarcopenia, ultrasound fat mass","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82503965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Primary and Preventive Care of Women 妇女初级保健和预防性保健
Pub Date : 2018-07-01 DOI: 10.2310/TYWC.1068
J. Henrich
Women’s health can be defined as diseases or conditions that are unique to women or that involve gender differences that are particularly important to women. This definition acknowledges the increasing scientific evidence supporting a focus on sex and gender and expands the concept of women’s health beyond the traditional focus on reproductive organs and their function. Over time, the definition has come to include an appreciation of wellness and prevention, the interdisciplinary and holistic nature of women’s health, the diversity of women and their health needs over the life span, and the central role of women as patients and as active participants in their health care. This broader interdisciplinary perspective has important implications for clinicians providing care to women. In addition to understanding basic female physiology and reproductive biology, clinicians need to appreciate the complex interaction between the environment and the biology and psychosocial development of women. When dealing with conditions that are not specific to women, clinicians need to be aware of those aspects of disease that are different in women or have important gender implications. The ability to apply this information requires that clinicians adopt attitudes and behavior that are culturally and gender sensitive. Figures visualize female life expectancy, age-adjusted death rates, female breast cancer incidence and death rates, trends in female cigarette smoking, and the U.S. Preventive Services Task Force guidelines for preventive primary care in women. This review contains 5 figures, 6 tables and 56 references.
妇女健康可以定义为妇女特有的疾病或状况,或涉及对妇女特别重要的性别差异的疾病或状况。这一定义承认越来越多的科学证据支持注重性和社会性别,并将妇女健康的概念扩展到传统的注重生殖器官及其功能之外。随着时间的推移,这一定义已包括对保健和预防、妇女保健的跨学科和整体性质、妇女及其一生中保健需求的多样性以及妇女作为病人和积极参与其保健的中心作用的赞赏。这种更广泛的跨学科视角对临床医生为妇女提供护理具有重要意义。除了了解基本的女性生理学和生殖生物学外,临床医生还需要了解环境与女性生物学和社会心理发展之间复杂的相互作用。在处理非女性特有的疾病时,临床医生需要意识到疾病在女性身上的不同方面或具有重要的性别影响。应用这些信息的能力要求临床医生采取对文化和性别敏感的态度和行为。数字显示了女性预期寿命、年龄调整死亡率、女性乳腺癌发病率和死亡率、女性吸烟趋势以及美国预防服务工作队关于妇女预防性初级保健的指导方针。本综述共包含图5张,表6张,参考文献56篇。
{"title":"Primary and Preventive Care of Women","authors":"J. Henrich","doi":"10.2310/TYWC.1068","DOIUrl":"https://doi.org/10.2310/TYWC.1068","url":null,"abstract":"Women’s health can be defined as diseases or conditions that are unique to women or that involve gender differences that are particularly important to women. This definition acknowledges the increasing scientific evidence supporting a focus on sex and gender and expands the concept of women’s health beyond the traditional focus on reproductive organs and their function. Over time, the definition has come to include an appreciation of wellness and prevention, the interdisciplinary and holistic nature of women’s health, the diversity of women and their health needs over the life span, and the central role of women as patients and as active participants in their health care. This broader interdisciplinary perspective has important implications for clinicians providing care to women. In addition to understanding basic female physiology and reproductive biology, clinicians need to appreciate the complex interaction between the environment and the biology and psychosocial development of women. When dealing with conditions that are not specific to women, clinicians need to be aware of those aspects of disease that are different in women or have important gender implications. The ability to apply this information requires that clinicians adopt attitudes and behavior that are culturally and gender sensitive. Figures visualize female life expectancy, age-adjusted death rates, female breast cancer incidence and death rates, trends in female cigarette smoking, and the U.S. Preventive Services Task Force guidelines for preventive primary care in women. \u0000This review contains 5 figures, 6 tables and 56 references.","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88020297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic Organ Prolapse 盆腔器官脱垂
Pub Date : 2018-06-30 DOI: 10.2310/im.1308
L. Hoyte, R. Bassaly, S. Hart, M. McCullough, E. Jackson
Pelvic organ prolapse (POP) is the descent of one of more aspects of the vagina and/or uterus. Evaluation of POP always begins with a thorough history and physical examination. Management choices include observation, conservative options, and surgical options. Surgical management is divided into two categories, which are restorative and obliterative. It is important to counsel patients that although POP may affect quality of life, it is not life-threatening. This chapter is designed to guide the healthcare provider with a review of epidemiology, anatomy, evaluation, and management of POP. The chapter contains 14 figures that illustrate examples of common examination findings, devices, and treatment options. Also, there are 5 tables that provide concise reference materials to help guide the healthcare provider.This review contains 91 references, 14 figures, and 6 tables.Key Words: constipation, mesh, pain, pelvic floor, pessary, POP-Q, risk factors, surgery, vaginal wall
盆腔器官脱垂(POP)是阴道和/或子宫的多个方面之一的下降。对POP的评估总是从彻底的病史和体格检查开始。治疗选择包括观察、保守治疗和手术治疗。手术治疗分为两类,恢复性和闭塞性。重要的是要告知患者,虽然POP可能影响生活质量,但它不会危及生命。本章旨在指导医疗保健提供者与流行病学,解剖学,评估和管理POP的审查。本章包含14个图,说明了常见检查结果,设备和治疗方案的例子。此外,还有5个表格提供了简明的参考材料,以帮助指导医疗保健提供者。本文共收录文献91篇,图14张,表6张。关键词:便秘,补片,疼痛,盆底,子宫托,POP-Q,危险因素,手术,阴道壁
{"title":"Pelvic Organ Prolapse","authors":"L. Hoyte, R. Bassaly, S. Hart, M. McCullough, E. Jackson","doi":"10.2310/im.1308","DOIUrl":"https://doi.org/10.2310/im.1308","url":null,"abstract":"Pelvic organ prolapse (POP) is the descent of one of more aspects of the vagina and/or uterus. Evaluation of POP always begins with a thorough history and physical examination. Management choices include observation, conservative options, and surgical options. Surgical management is divided into two categories, which are restorative and obliterative. It is important to counsel patients that although POP may affect quality of life, it is not life-threatening. This chapter is designed to guide the healthcare provider with a review of epidemiology, anatomy, evaluation, and management of POP. The chapter contains 14 figures that illustrate examples of common examination findings, devices, and treatment options. Also, there are 5 tables that provide concise reference materials to help guide the healthcare provider.\u0000This review contains 91 references, 14 figures, and 6 tables.\u0000Key Words: constipation, mesh, pain, pelvic floor, pessary, POP-Q, risk factors, surgery, vaginal wall","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81119110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substance Use Disorders 物质使用障碍
Pub Date : 2018-06-25 DOI: 10.2310/im.1191
F. Moeller
There is a consistent body of evidence showing that substance abuse and dependence can worsen preexisting medical conditions, can temporarily mimic medical and psychiatric disorders, and can themselves cause medical problems, including life-threatening overdose. Substance use disorders are common in young and middle-aged persons: the lifetime prevalence of these syndromes, including alcoholism, is over 20% for men and about 15% for women. This chapter discusses dependence, abuse, substance use disorder, and substance-induced disorders involving depressants, stimulants, opioids, cannabinoids, hallucinogens, N-methyl-D-aspartate (NMDA) receptor channel blockers, and inhalants. Epidemiology, etiology, pathophysiology, diagnosis (including clinical assessment and laboratory tests), and treatment are reviewed. Treatment of intoxication, overdose, withdrawal, and rehabilitation is discussed. A figure illustrates the neurocircuitry of addiction. Tables describe the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) diagnostic criteria for abuse and dependence; frequently misused drugs; neural effects of commonly abused drugs; the natural history of drug dependence; conditions affecting the outcome of urinary drug tests; and pharmacologic options for treatment of drug overdose. This chapter contains 112 references.
有一致的证据表明,药物滥用和依赖会使先前存在的医疗状况恶化,可能暂时模仿医疗和精神疾病,并且本身可能导致医疗问题,包括危及生命的过量服用。物质使用障碍在青年和中年人中很常见:包括酗酒在内的这些综合征的终生患病率在男性中超过20%,在女性中约为15%。本章讨论了依赖性、滥用、物质使用障碍和物质引起的障碍,包括抑制剂、兴奋剂、阿片类药物、大麻素、致幻剂、n -甲基- d -天冬氨酸(NMDA)受体通道阻滞剂和吸入剂。对流行病学、病因学、病理生理学、诊断(包括临床评估和实验室检查)和治疗进行了综述。治疗中毒,过量,戒断和康复讨论。这张图说明了成瘾的神经回路。表格描述了精神障碍诊断和统计手册,第四版(DSM-IV)滥用和依赖的诊断标准;经常滥用药物;常见滥用药物的神经效应;药物依赖的自然历史;影响尿药检结果的情况;以及药物过量治疗的药物选择。本章共有112处参考文献。
{"title":"Substance Use Disorders","authors":"F. Moeller","doi":"10.2310/im.1191","DOIUrl":"https://doi.org/10.2310/im.1191","url":null,"abstract":"There is a consistent body of evidence showing that substance abuse and dependence can worsen preexisting medical conditions, can temporarily mimic medical and psychiatric disorders, and can themselves cause medical problems, including life-threatening overdose. Substance use disorders are common in young and middle-aged persons: the lifetime prevalence of these syndromes, including alcoholism, is over 20% for men and about 15% for women. This chapter discusses dependence, abuse, substance use disorder, and substance-induced disorders involving depressants, stimulants, opioids, cannabinoids, hallucinogens, N-methyl-D-aspartate (NMDA) receptor channel blockers, and inhalants. Epidemiology, etiology, pathophysiology, diagnosis (including clinical assessment and laboratory tests), and treatment are reviewed. Treatment of intoxication, overdose, withdrawal, and rehabilitation is discussed. A figure illustrates the neurocircuitry of addiction. Tables describe the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) diagnostic criteria for abuse and dependence; frequently misused drugs; neural effects of commonly abused drugs; the natural history of drug dependence; conditions affecting the outcome of urinary drug tests; and pharmacologic options for treatment of drug overdose. This chapter contains 112 references.","PeriodicalId":11220,"journal":{"name":"DeckerMed Medicine","volume":"234 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73955534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
DeckerMed Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1